These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 32359402)

  • 1. Considering BCG vaccination to reduce the impact of COVID-19.
    Curtis N; Sparrow A; Ghebreyesus TA; Netea MG
    Lancet; 2020 May; 395(10236):1545-1546. PubMed ID: 32359402
    [No Abstract]   [Full Text] [Related]  

  • 2. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCG Vaccination Policy and Protection Against COVID-19: Correspondence.
    Mohapatra PR; Mishra B
    Indian J Pediatr; 2020 Sep; 87(9):772-773. PubMed ID: 32779000
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
    Ayoub BM
    Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
    [No Abstract]   [Full Text] [Related]  

  • 5. The bacillus Calmette-Guérin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Patella V; Delfino G; Bruzzese D; Giuliano A; Sanduzzi A
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25205-25206. PubMed ID: 32994349
    [No Abstract]   [Full Text] [Related]  

  • 6. [DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany - (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2)].
    Otto-Knapp R; Häcker B; Breuer C; Diel R; Kaufmann SHE; Korr G; Pfeiffer M; Schaberg T; Schönfeld N; Witte P; Bauer T
    Pneumologie; 2020 Jul; 74(7):412-416. PubMed ID: 32674189
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG versus COVID-19?
    Kantor IN
    Medicina (B Aires); 2020; 80(3):292-294. PubMed ID: 32442946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
    Huang W; Liu T; Feng G; Wang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1044-1048. PubMed ID: 33210600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
    Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
    Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guérin (BCG) vaccination on COVID-19 prevalence and mortality.
    Barillas-Mury C; Escobar LE; Molina-Cruz A
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25207-25208. PubMed ID: 32994348
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG Vaccination Policy and Protection Against COVID-19.
    Meena J; Yadav A; Kumar J
    Indian J Pediatr; 2020 Sep; 87(9):749. PubMed ID: 32519258
    [No Abstract]   [Full Text] [Related]  

  • 12. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
    Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
    Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of evidence for BCG vaccine protection from severe COVID-19.
    Lindestam Arlehamn CS; Sette A; Peters B
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25203-25204. PubMed ID: 32994350
    [No Abstract]   [Full Text] [Related]  

  • 15. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Tomita Y; Sato R; Ikeda T; Sakagami T
    Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concern over a COVID-19-related BCG shortage.
    Namkoong H; Horita N; Ebina-Shibuya R
    Int J Tuberc Lung Dis; 2020 Jun; 24(6):642-643. PubMed ID: 32552997
    [No Abstract]   [Full Text] [Related]  

  • 17. Relation between BCG coverage rate and COVID-19 infection worldwide.
    Macedo A; Febra C
    Med Hypotheses; 2020 Sep; 142():109816. PubMed ID: 32408071
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotics - Self Medication, BCG Scar and the On-Going Challenge of Covid-19.
    Erhabor GE
    West Afr J Med; 2020 Oct; 37(5):435-437. PubMed ID: 33058115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
    Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
    J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy.
    Koti M; Morales A; Graham CH; Siemens DR
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32636240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.